1.7M XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 1,375 | 4,125 | - | - | Restricted Stock Unit (RSU) | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 6,625 | 257,008 | - | - | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 11.96 per share. | 15 Feb 2025 | 4,370 | 252,638 | - | 12.0 | 52,278 | Common Stock |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 1,375 | 241,508 | - | - | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 2,250 | 243,758 | - | - | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 6,625 | 250,383 | - | - | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 6,625 | 99,375 | - | - | Restricted Stock Unit (RSU) | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 6,625 | 72,875 | - | - | Restricted Stock Unit (RSU) | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 2,250 | 15,750 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 1,750 | 12,250 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,687 | 40,565 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,687 | 55,313 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 2,962 | 35,124 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 1,750 | 36,874 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,687 | 40,561 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,687 | 44,248 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 11.96 per share. | 15 Feb 2025 | 4,646 | 39,602 | - | 12.0 | 55,580 | Common Stock |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 2,962 | 20,740 | - | - | Restricted Stock Unit (RSU) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 11.96 per share. | 15 Feb 2025 | 12,048 | 128,015 | - | 12.0 | 144,130 | Common Stock |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,562 | 111,939 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 4,750 | 116,689 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 11,687 | 128,376 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 11,687 | 140,063 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 3,562 | 10,694 | - | - | Restricted Stock Unit (RSU) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 4,750 | 33,250 | - | - | Restricted Stock Unit (RSU) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 11,687 | 128,565 | - | - | Restricted Stock Unit (RSU) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2025 | 11,687 | 175,313 | - | - | Restricted Stock Unit (RSU) | |
| Charles N. York | COO, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 162,000 | 162,000 | - | - | Stock Option (right to buy Common Stock) | |
| Charles N. York | COO, CFO AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 106,000 | 106,000 | - | - | Restricted Stock Units | |
| Adam Dubow | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 90,000 | 90,000 | - | - | Stock Option (right to buy Common Stock) | |
| Adam Dubow | GENERAL COUNSEL | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 59,000 | 59,000 | - | - | Restricted Stock Units | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 286,000 | 286,000 | - | - | Stock Option (right to buy Common Stock) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2025 | 187,000 | 187,000 | - | - | Restricted Stock Units | |
| Blackman Samuel | HEAD OF R&D | 10 Dec 2024 | 30,000 | 1,034,015 | - | 13.3 | 399,339 | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 2,250 | 18,000 | - | - | Restricted Stock Unit (RSU) | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 1,375 | 5,500 | - | - | Restricted Stock Unit (RSU) | |
| Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 13.21 per share. | 15 Nov 2024 | 2,602 | 240,133 | - | 13.2 | 34,373 | Common Stock |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 6,625 | 242,735 | - | - | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 2,250 | 236,110 | - | - | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 1,375 | 233,860 | - | - | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 6,625 | 79,500 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 2,962 | 29,890 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 1,750 | 31,640 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 3,687 | 35,327 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 13.21 per share. | 15 Nov 2024 | 3,165 | 32,162 | - | 13.2 | 41,810 | Common Stock |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 2,962 | 23,702 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 1,750 | 14,000 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 3,687 | 44,252 | - | - | Restricted Stock Unit (RSU) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 13.21 per share. | 15 Nov 2024 | 10,554 | 108,377 | - | 13.2 | 139,420 | Common Stock |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 11,687 | 118,931 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 4,750 | 107,244 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 3,562 | 102,494 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 11,687 | 140,252 | - | - | Restricted Stock Unit (RSU) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 4,750 | 38,000 | - | - | Restricted Stock Unit (RSU) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2024 | 3,562 | 14,256 | - | - | Restricted Stock Unit (RSU) | |
| Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 1,437 | 1,060,159 | - | - | Common Stock | ||
| Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 1,187 | 1,058,722 | - | - | Common Stock | ||
| Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 6,062 | 72,752 | - | - | Restricted Stock Unit (RSU) | ||
| Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 1,437 | 11,504 | - | - | Restricted Stock Unit (RSU) | ||
| Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 1,187 | 4,756 | - | - | Restricted Stock Unit (RSU) | ||
| Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 2,206 | 1,064,015 | - | 13.2 | 29,142 | Common Stock | |
| Samuel Blackman | HEAD OF R&D | 15 Nov 2024 | 6,062 | 1,066,221 | - | - | Common Stock | ||
| Samuel Blackman | HEAD OF R&D | 08 Nov 2024 | 18,255 | 1,067,535 | - | 16.2 | 295,229 | Common Stock | |
| Samuel Blackman | HEAD OF R&D | 08 Nov 2024 | 10,000 | 1,057,535 | - | 16.1 | 160,994 | Common Stock | |
| Samuel Blackman | HEAD OF R&D | 07 Nov 2024 | 11,245 | 1,085,790 | - | 16.0 | 180,287 | Common Stock | |
| Samuel Blackman | HEAD OF R&D | 31 Oct 2024 | 500 | 1,097,035 | - | 16.0 | 8,010 | Common Stock | |
| Samuel Blackman | HEAD OF R&D | 10 Sep 2024 | 30,000 | 1,097,535 | - | 14.2 | 426,675 | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 6,625 | 86,125 | - | - | Restricted Stock Unit (RSU) | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 1,375 | 226,243 | - | - | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 2,250 | 228,493 | - | - | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 6,625 | 235,118 | - | - | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 15 Aug 2024 | 2,633 | 232,485 | - | 14.0 | 36,860 | Common Stock |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 1,375 | 6,875 | - | - | Restricted Stock Unit (RSU) | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 2,250 | 20,250 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 3,687 | 47,939 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 2,962 | 24,693 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 1,750 | 26,443 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 3,687 | 30,130 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 15 Aug 2024 | 3,202 | 26,928 | - | 14.0 | 44,825 | Common Stock |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 2,962 | 26,664 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 1,750 | 15,750 | - | - | Restricted Stock Unit (RSU) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 4,750 | 97,926 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 14.00 per share. | 15 Aug 2024 | 10,681 | 98,932 | - | 14.0 | 149,524 | Common Stock |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 11,687 | 109,613 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 3,562 | 93,176 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 11,687 | 151,939 | - | - | Restricted Stock Unit (RSU) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 4,750 | 42,750 | - | - | Restricted Stock Unit (RSU) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2024 | 3,562 | 17,818 | - | - | Restricted Stock Unit (RSU) | |
| Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 1,187 | 1,122,268 | - | - | Common Stock | ||
| Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 1,437 | 1,123,705 | - | - | Common Stock | ||
| Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 6,062 | 1,129,767 | - | - | Common Stock | ||
| Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 2,232 | 1,127,535 | - | 14.0 | 31,246 | Common Stock | |
| Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 1,187 | 5,943 | - | - | Restricted Stock Unit (RSU) | ||
| Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 1,437 | 12,941 | - | - | Restricted Stock Unit (RSU) | ||
| Samuel Blackman | HEAD OF R&D | 15 Aug 2024 | 6,062 | 78,814 | - | - | Restricted Stock Unit (RSU) | ||
| Samuel Blackman | HEAD OF R&D | 16 Jul 2024 | 20,000 | 1,121,081 | - | 16.0 | 320,226 | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 59,075 | 162,762 | - | 0 | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 80,619 | 219,406 | - | 0 | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 80,619 | 734,414 | - | 0 | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 72,612 | 197,614 | - | 0 | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 72,612 | 807,026 | - | 0 | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 29,606 | 653,795 | - | 0 | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 29,606 | 222,030 | - | 0 | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Gift of securities by or to the insider at price $ 0.00 per share. | 02 Jul 2024 | 59,075 | 624,189 | - | 0 | Common Stock | |
| Saira Ramasastry | Director | Sale of securities on an exchange or to another person at price $ 13.19 per share. | 21 Jun 2024 | 10,000 | 40,485 | - | 13.2 | 131,877 | Common Stock |
| Samuel Blackman | HEAD OF R&D | 10 Jun 2024 | 30,000 | 1,141,081 | - | 12.6 | 378,588 | Common Stock | |
| Saira Ramasastry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Natalie C. Holles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Habib Joseph Dable | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| William Grossman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| John A. Josey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Michael Gladstone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 32,335 | 32,335 | - | - | Stock Option (right to buy Common Stock) | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 1,375 | 8,250 | - | - | Restricted Stock Unit (RSU) | |
| Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 16.08 per share. | 15 May 2024 | 2,675 | 224,868 | - | 16.1 | 43,011 | Common Stock |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 6,625 | 227,543 | - | - | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,250 | 220,918 | - | - | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 1,375 | 218,668 | - | - | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 6,625 | 92,750 | - | - | Restricted Stock Unit (RSU) | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,250 | 22,500 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 16.08 per share. | 15 May 2024 | 3,253 | 21,731 | - | 16.1 | 52,304 | Common Stock |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,962 | 29,626 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 1,750 | 17,500 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 3,687 | 51,626 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 2,962 | 19,547 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 1,750 | 21,297 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 3,687 | 24,984 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 4,750 | 650,914 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 4,750 | 47,500 | - | - | Restricted Stock Unit (RSU) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 3,562 | 21,380 | - | - | Restricted Stock Unit (RSU) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 16.08 per share. | 15 May 2024 | 7,873 | 654,728 | - | 16.1 | 126,588 | Common Stock |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 11,687 | 662,601 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 11,687 | 163,626 | - | - | Restricted Stock Unit (RSU) | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2024 | 3,562 | 646,164 | - | - | Common Stock | |
| Samuel Blackman | HEAD OF R&D | 15 May 2024 | 1,437 | 1,167,286 | - | - | Common Stock | ||
| Samuel Blackman | HEAD OF R&D | 15 May 2024 | 1,187 | 1,165,849 | - | - | Common Stock | ||
| Samuel Blackman | HEAD OF R&D | 15 May 2024 | 6,062 | 1,173,348 | - | - | Common Stock | ||
| Samuel Blackman | HEAD OF R&D | 15 May 2024 | 2,267 | 1,171,081 | - | 16.1 | 36,450 | Common Stock | |
| Samuel Blackman | HEAD OF R&D | 15 May 2024 | 1,187 | 7,130 | - | - | Restricted Stock Unit (RSU) | ||
| Samuel Blackman | HEAD OF R&D | 15 May 2024 | 1,437 | 14,378 | - | - | Restricted Stock Unit (RSU) | ||
| Samuel Blackman | HEAD OF R&D | 15 May 2024 | 6,062 | 84,876 | - | - | Restricted Stock Unit (RSU) | ||
| Samuel Blackman | HEAD OF R&D | 10 May 2024 | 10,000 | 1,164,662 | - | 16.4 | 163,743 | Common Stock | |
| Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 17.85 per share. | 01 May 2024 | 8,078 | 217,293 | - | 17.9 | 144,214 | Common Stock |
| Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 17.90 per share. | 01 May 2024 | 200 | 225,371 | - | 17.9 | 3,579 | Common Stock |
| Charles N. York | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 17.89 per share. | 01 May 2024 | 52,183 | 225,571 | - | 17.9 | 933,397 | Common Stock |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 17.85 per share. | 01 May 2024 | 9,154 | 642,602 | - | 17.9 | 163,417 | Common Stock |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 17.88 per share. | 01 May 2024 | 70,051 | 651,762 | - | 17.9 | 1,252,183 | Common Stock |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 18.00 per share. | 01 May 2024 | 6 | 651,756 | - | 18 | 108 | Common Stock |
| Samuel Blackman | HEAD OF R&D | 18 Apr 2024 | 10,000 | 1,174,662 | - | 16.0 | 160,163 | Common Stock | |
| Samuel Blackman | HEAD OF R&D | 25 Mar 2024 | 10,000 | 1,184,662 | - | 16.0 | 160,055 | Common Stock | |
| Samuel Blackman | HEAD OF R&D | 11 Mar 2024 | 30,000 | 1,194,662 | - | 15.2 | 457,314 | Common Stock | |
| Samuel Blackman | HEAD OF R&D | 27 Feb 2024 | 20,000 | 1,224,662 | - | 16.1 | 322,166 | Common Stock | |
| Bender Jeremy | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 4,750 | 52,250 | - | - | Restricted Stock Unit (RSU) | |
| N. York Charles | COO, CFO AND SECRETARY | Sale of securities on an exchange or to another person at price $ 15.25 per share. | 15 Feb 2024 | 2,666 | 277,754 | - | 15.2 | 40,651 | Common Stock |
| York N. Charles | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 2,250 | 273,795 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 11,687 | 729,428 | - | - | Common Stock | |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 15.25 per share. | 15 Feb 2024 | 7,615 | 721,813 | - | 15.2 | 116,114 | Common Stock |
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 3,562 | 712,991 | - | - | Common Stock | |
| Bender Jeremy | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 11,687 | 175,313 | - | - | Restricted Stock Unit (RSU) | |
| Charles N. York | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 6,625 | 280,420 | - | - | Common Stock | |
| Bender Jeremy | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 3,562 | 24,942 | - | - | Restricted Stock Unit (RSU) | |
| Blackman Samuel | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 1,437 | 1,240,858 | - | - | Common Stock | ||
| York Charles N. | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,375 | 9,625 | - | - | Restricted Stock Unit (RSU) | |
| York Charles N. | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 2,250 | 24,750 | - | - | Restricted Stock Unit (RSU) | |
| Blackman Samuel | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 1,187 | 8,317 | - | - | Restricted Stock Unit (RSU) | ||
| Jeremy Bender | Director, CHIEF EXECUTIVE OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 4,750 | 717,741 | - | - | Common Stock | |
| Blackman Samuel | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 1,437 | 15,815 | - | - | Restricted Stock Unit (RSU) | ||
| Samuel Blackman | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 6,062 | 90,938 | - | - | Restricted Stock Unit (RSU) | ||
| Blackman Samuel | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 2,258 | 1,244,662 | - | 15.2 | 34,430 | Common Stock | |
| Blackman Samuel | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 6,062 | 1,246,920 | - | - | Common Stock | ||
| Charles York N. | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,375 | 271,545 | - | - | Common Stock | |
| N. York Charles | COO, CFO AND SECRETARY | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 6,625 | 99,375 | - | - | Restricted Stock Unit (RSU) | |
| Samuel Blackman | HEAD OF RESEARCH AND DEVELOPME | 15 Feb 2024 | 1,187 | 1,239,421 | - | - | Common Stock | ||
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 2,962 | 32,588 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 3,687 | 19,827 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,750 | 16,140 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 2,962 | 14,390 | - | - | Common Stock | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 3,687 | 55,313 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2024 | 1,750 | 19,250 | - | - | Restricted Stock Unit (RSU) | |
| Adam Dubow | GENERAL COUNSEL | Sale of securities on an exchange or to another person at price $ 15.25 per share. | 15 Feb 2024 | 3,242 | 16,585 | - | 15.2 | 49,434 | Common Stock |
| Grossman William | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 66,660 | 66,660 | - | - | Stock Option (right to buy Common Stock) | |
| J. Dable Habib | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2024 | 66,660 | 66,660 | - | - | Stock Option (right to buy Common Stock) | |
| Jeremy Bender | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 187,000 | 187,000 | - | - | Restricted Stock Units | |
| N. Charles York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 162,000 | 162,000 | - | - | Stock Option (right to buy Common Stock) | |
| Blackman Samuel | Head of Research and Developme | 05 Jan 2024 | 97,000 | 97,000 | - | - | Restricted Stock Units | ||
| Bender Jeremy | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 286,000 | 286,000 | - | - | Stock Option (right to buy Common Stock) | |
| York Charles N. | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 106,000 | 106,000 | - | - | Restricted Stock Units | |
| Blackman Samuel | Head of Research and Developme | 05 Jan 2024 | 148,000 | 148,000 | - | - | Stock Option (right to buy Common Stock) | ||
| Adam Dubow | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 90,000 | 90,000 | - | - | Stock Option (right to buy Common Stock) | |
| Adam Dubow | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 59,000 | 59,000 | - | - | Restricted Stock Units | |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 2,250 | 268,423 | - | - | Common Stock | |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 1,375 | 266,173 | - | - | Common Stock | |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 13.86 per share. | 15 Aug 2023 | 922 | 267,501 | - | 13.9 | 12,779 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 1,375 | 12,375 | - | - | Restricted Stock Units | |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 2,250 | 29,250 | - | - | Restricted Stock Units | |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 3,562 | 702,470 | - | - | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.86 per share. | 15 Aug 2023 | 2,996 | 704,224 | - | 13.9 | 41,525 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 4,750 | 707,220 | - | - | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 4,750 | 61,750 | - | - | Restricted Stock Units | |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2023 | 3,562 | 32,066 | - | - | Restricted Stock Units | |
| Samuel Blackman | Head of Research and Developme | 15 Aug 2023 | 1,437 | 18,689 | - | - | Restricted Stock Units | ||
| Samuel Blackman | Head of Research and Developme | 15 Aug 2023 | 1,187 | 10,691 | - | - | Restricted Stock Units | ||
| Samuel Blackman | Head of Research and Developme | 15 Aug 2023 | 668 | 1,236,319 | - | 13.9 | 9,258 | Common Stock | |
| Samuel Blackman | Head of Research and Developme | 15 Aug 2023 | 1,437 | 1,236,987 | - | - | Common Stock | ||
| Samuel Blackman | Head of Research and Developme | 15 Aug 2023 | 1,187 | 1,235,550 | - | - | Common Stock | ||
| Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 240,288 | 240,288 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 29,938 | 270,226 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 29,938 | 251,636 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 59,737 | 300,025 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 59,737 | 221,837 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 240,288 | 0 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 240,288 | 240,288 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Jul 2023 | 240,288 | 698,908 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 01 Jul 2023 | 240,288 | 240,288 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 01 Jul 2023 | 240,288 | 939,196 | - | 0 | Common Stock | |
| Saira Ramasastry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 37,500 | 37,500 | - | - | Director Stock Option (Right to buy Common Stock) | |
| Natalie C. Holles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 37,500 | 37,500 | - | - | Director Stock Option (Right to buy Common Stock) | |
| Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 37,500 | 37,500 | - | - | Director Stock Option (Right to buy Common Stock) | |
| Daniel Becker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 37,500 | 37,500 | - | - | Director Stock Option (Right to buy Common Stock) | |
| John A. Josey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 37,500 | 37,500 | - | - | Director Stock Option (Right to buy Common Stock) | |
| Michael Gladstone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 37,500 | 37,500 | - | - | Director Stock Option (Right to buy Common Stock) | |
| Samuel Blackman | Chief Medical Officer | 05 Jun 2023 | 1,229 | 1,234,363 | - | 16 | 19,664 | Common Stock | |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 1,375 | 263,503 | - | - | Common Stock | |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 1,375 | 13,750 | - | - | Restricted Stock Units | |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 13.12 per share. | 15 May 2023 | 955 | 264,798 | - | 13.1 | 12,532 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 2,250 | 31,500 | - | - | Restricted Stock Units | |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 2,250 | 265,753 | - | - | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 3,562 | 35,628 | - | - | Restricted Stock Units | |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 4,750 | 66,500 | - | - | Restricted Stock Units | |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 3,562 | 1,177,838 | - | - | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 4,750 | 1,182,588 | - | - | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 13.12 per share. | 15 May 2023 | 3,104 | 1,179,484 | - | 13.1 | 40,732 | Common Stock |
| Samuel Blackman | Chief Medical Officer | 15 May 2023 | 1,437 | 1,236,284 | - | - | Common Stock | ||
| Samuel Blackman | Chief Medical Officer | 15 May 2023 | 1,187 | 1,234,847 | - | - | Common Stock | ||
| Samuel Blackman | Chief Medical Officer | 15 May 2023 | 692 | 1,235,592 | - | 13.1 | 9,081 | Common Stock | |
| Samuel Blackman | Chief Medical Officer | 15 May 2023 | 1,187 | 11,878 | - | - | Restricted Stock Units | ||
| Samuel Blackman | Chief Medical Officer | 15 May 2023 | 1,437 | 20,126 | - | - | Restricted Stock Units | ||
| Samuel Blackman | Chief Medical Officer | 10 Mar 2023 | 10,000 | 1,233,660 | - | 18.0 | 180,484 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 07 Mar 2023 | 12,500 | 1,174,276 | - | 20.0 | 250,114 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 17 Feb 2023 | 9,377 | 262,128 | - | 20.0 | 187,790 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 2,250 | 272,435 | - | - | Common Stock | |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 2,250 | 33,750 | - | - | Restricted Stock Units | |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 1,375 | 15,125 | - | - | Restricted Stock Units | |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 19.57 per share. | 15 Feb 2023 | 930 | 271,505 | - | 19.6 | 18,203 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 1,375 | 270,185 | - | - | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 3,562 | 1,185,048 | - | - | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 4,750 | 71,250 | - | - | Restricted Stock Units | |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 3,562 | 39,190 | - | - | Restricted Stock Units | |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.57 per share. | 15 Feb 2023 | 3,022 | 1,186,776 | - | 19.6 | 59,150 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 4,750 | 1,189,798 | - | - | Common Stock | |
| Samuel Blackman | Chief Medical Officer | 15 Feb 2023 | 1,437 | 21,563 | - | - | Restricted Stock Units | ||
| Samuel Blackman | Chief Medical Officer | 15 Feb 2023 | 1,187 | 13,065 | - | - | Restricted Stock Units | ||
| Samuel Blackman | Chief Medical Officer | 15 Feb 2023 | 674 | 1,243,660 | - | 19.6 | 13,192 | Common Stock | |
| Samuel Blackman | Chief Medical Officer | 15 Feb 2023 | 1,437 | 1,244,334 | - | - | Common Stock | ||
| Samuel Blackman | Chief Medical Officer | 15 Feb 2023 | 1,187 | 1,242,897 | - | - | Common Stock | ||
| Samuel Blackman | Chief Medical Officer | 10 Feb 2023 | 10,000 | 1,241,710 | - | 20.1 | 200,659 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 22.00 per share. | 23 Jan 2023 | 12,500 | 1,181,486 | - | 22.0 | 274,988 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 22.75 per share. | 20 Jan 2023 | 10,000 | 268,810 | - | 22.8 | 227,523 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 36,000 | 36,000 | - | - | Restricted Stock Units | |
| Charles N. York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 116,000 | 116,000 | - | - | Stock Option (right to buy Common Stock) | |
| Jeremy Bender | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 76,000 | 76,000 | - | - | Restricted Stock Units | |
| Jeremy Bender | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jan 2023 | 244,000 | 244,000 | - | - | Stock Option (right to buy Common Stock) | |
| Samuel Blackman | Chief Medical Officer | 17 Jan 2023 | 72,000 | 72,000 | - | - | Stock Option (right to buy Common Stock) | ||
| Samuel Blackman | Chief Medical Officer | 17 Jan 2023 | 23,000 | 23,000 | - | - | Restricted Stock Units | ||
| Samuel Blackman | Chief Medical Officer | 10 Jan 2023 | 2,500 | 1,250,148 | - | 23.2 | 58,011 | Common Stock | |
| Samuel Blackman | Chief Medical Officer | 10 Jan 2023 | 7,500 | 1,252,648 | - | 22.8 | 170,633 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 281,574 | 1,192,424 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 281,574 | 281,574 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 281,574 | 1,192,424 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 281,574 | 281,574 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.32 per share. | 21 Dec 2022 | 12,500 | 1,192,424 | - | 20.3 | 253,969 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.06 per share. | 20 Dec 2022 | 10,000 | 276,497 | - | 20.1 | 200,650 | Common Stock |
| Samuel Blackman | Chief Medical Officer | 01 Dec 2022 | 900 | 1,260,148 | - | 22.2 | 19,940 | Common Stock | |
| Samuel Blackman | Chief Medical Officer | 01 Dec 2022 | 9,100 | 1,261,048 | - | 21.4 | 194,590 | Common Stock | |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 21.39 per share. | 21 Nov 2022 | 300 | 286,497 | - | 21.4 | 6,417 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.74 per share. | 21 Nov 2022 | 9,700 | 286,797 | - | 20.7 | 201,153 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.38 per share. | 21 Nov 2022 | 400 | 1,204,924 | - | 21.4 | 8,552 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.74 per share. | 21 Nov 2022 | 12,100 | 1,205,324 | - | 20.7 | 250,927 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 21.46 per share. | 15 Nov 2022 | 430 | 296,497 | - | 21.5 | 9,228 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 1,375 | 16,500 | - | - | Restricted Stock Units | |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 1,375 | 295,776 | - | - | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 3,562 | 42,752 | - | - | Restricted Stock Units | |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 21.46 per share. | 15 Nov 2022 | 1,513 | 1,217,424 | - | 21.5 | 32,469 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 3,562 | 1,218,937 | - | - | Common Stock | |
| Samuel Blackman | Chief Medical Officer | 15 Nov 2022 | 1,187 | 1,270,525 | - | - | Common Stock | ||
| Samuel Blackman | Chief Medical Officer | 15 Nov 2022 | 377 | 1,270,148 | - | 21.5 | 8,090 | Common Stock | |
| Samuel Blackman | Chief Medical Officer | 15 Nov 2022 | 1,187 | 14,252 | - | - | Restricted Stock Units | ||
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 01 Nov 2022 | 10,000 | 294,401 | - | 20.0 | 200,313 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.03 per share. | 01 Nov 2022 | 12,500 | 1,215,375 | - | 20.0 | 250,355 | Common Stock |
| Samuel Blackman | Chief Medical Officer | 01 Nov 2022 | 10,000 | 1,269,338 | - | 20.0 | 200,050 | Common Stock | |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 03 Oct 2022 | 10,000 | 304,401 | - | 20.0 | 200,473 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 03 Oct 2022 | 12,500 | 1,227,875 | - | 20.1 | 250,646 | Common Stock |
| Samuel Blackman | Chief Medical Officer | 03 Oct 2022 | 10,000 | 1,279,338 | - | 20.0 | 199,852 | Common Stock | |
| Garry A. Nicholson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 33,900 | 33,900 | - | - | Stock Option (Right to buy Common Stock) | |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 23.16 per share. | 01 Sep 2022 | 8,606 | 315,795 | - | 23.2 | 199,309 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 23.80 per share. | 01 Sep 2022 | 1,394 | 314,401 | - | 23.8 | 33,175 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 23.15 per share. | 01 Sep 2022 | 10,641 | 1,242,234 | - | 23.2 | 246,354 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 23.79 per share. | 01 Sep 2022 | 1,859 | 1,240,375 | - | 23.8 | 44,227 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 23.15 per share. | 01 Sep 2022 | 10,641 | 1,242,234 | - | 23.2 | 246,354 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 23.79 per share. | 01 Sep 2022 | 1,859 | 1,240,375 | - | 23.8 | 44,227 | Common Stock |
| Samuel Blackman | Chief Medical Officer | 01 Sep 2022 | 8,411 | 1,290,927 | - | 23.1 | 194,643 | Common Stock | |
| Samuel Blackman | Chief Medical Officer | 01 Sep 2022 | 1,589 | 1,289,338 | - | 23.8 | 37,808 | Common Stock | |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 4,125 | 325,490 | - | 0 | Common Stock | |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 24.31 per share. | 15 Aug 2022 | 1,089 | 324,401 | - | 24.3 | 26,474 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 4,125 | 17,875 | - | - | Restricted Stock Units | |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 10,686 | 1,256,878 | - | 0 | Common Stock | |
| Jeremy Bender | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 10,686 | 46,314 | - | - | Restricted Stock Units | |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 24.31 per share. | 15 Aug 2022 | 4,003 | 1,252,875 | - | 24.3 | 97,313 | Common Stock |
| Samuel Blackman | Chief Medical Officer | 15 Aug 2022 | 3,561 | 1,300,279 | - | 0 | Common Stock | ||
| Samuel Blackman | Chief Medical Officer | 15 Aug 2022 | 941 | 1,299,338 | - | 24.3 | 22,876 | Common Stock | |
| Samuel Blackman | Chief Medical Officer | 15 Aug 2022 | 3,561 | 15,439 | - | - | Restricted Stock Units | ||
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.05 per share. | 04 Aug 2022 | 10,000 | 321,365 | - | 20.1 | 200,541 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 04 Aug 2022 | 12,500 | 1,246,192 | - | 20.0 | 250,021 | Common Stock |
| Samuel Blackman | Chief Medical Officer | 01 Aug 2022 | 10,000 | 1,296,718 | - | 16.9 | 168,810 | Common Stock | |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 18 Jul 2022 | 2,500 | 331,365 | - | 20 | 50,000 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 18 Jul 2022 | 2,600 | 1,258,692 | - | 20.0 | 52,003 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 08 Jul 2022 | 1,416 | 333,865 | - | 20 | 28,320 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 08 Jul 2022 | 1,795 | 1,261,292 | - | 20 | 35,900 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 01 Jul 2022 | 800 | 335,281 | - | 20 | 16,000 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 01 Jul 2022 | 1,479 | 336,081 | - | 20 | 29,580 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 01 Jul 2022 | 857 | 1,263,087 | - | 20 | 17,140 | Common Stock |
| Jeremy Bender | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 20.00 per share. | 01 Jul 2022 | 1,746 | 1,263,944 | - | 20 | 34,920 | Common Stock |
| Samuel Blackman | Chief Medical Officer | 01 Jul 2022 | 3,309 | 1,307,585 | - | 19.2 | 63,625 | Common Stock | |
| Samuel Blackman | Chief Medical Officer | 01 Jul 2022 | 5,824 | 1,310,894 | - | 18.2 | 106,237 | Common Stock | |
| Samuel Blackman | Chief Medical Officer | 01 Jul 2022 | 867 | 1,306,718 | - | 19.9 | 17,296 | Common Stock | |
| Saira Ramasastry | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 28,700 | 28,700 | - | - | Director Stock Option (Right to buy Common Stock) | |
| Natalie C. Holles | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 28,700 | 28,700 | - | - | Director Stock Option (Right to buy Common Stock) | |
| Dan Becker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 28,700 | 28,700 | - | - | Director Stock Option (Right to buy Common Stock) | |
| John A. Josey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 28,700 | 28,700 | - | - | Director Stock Option (Right to buy Common Stock) | |
| Michael Gladstone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jun 2022 | 28,700 | 28,700 | - | - | Director Stock Option (Right to buy Common Stock) | |
| Michael Gladstone | Director | Purchase of securities on an exchange or from another person at price $ 15.00 per share. | 17 Jun 2022 | 766,667 | 766,667 | - | 15 | 11,500,005 | Common Stock |
| Charles N. York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 151,000 | 151,000 | - | - | Stock Option (right to buy Common Stock) | |
| Charles N. York | COO, CFO and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 22,000 | 22,000 | - | - | Restricted Stock Units | |
| Jeremy Bender | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 57,000 | 57,000 | - | - | Restricted Stock Units | |
| Jeremy Bender | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jan 2022 | 397,000 | 397,000 | - | - | Stock Option (right to buy Common Stock) | |
| Samuel Blackman | Chief Medical Officer | 18 Jan 2022 | 19,000 | 19,000 | - | - | Restricted Stock Units | ||
| Samuel Blackman | Chief Medical Officer | 18 Jan 2022 | 135,000 | 135,000 | - | - | Stock Option (right to buy Common Stock) | ||
| Samuel Blackman | Chief Medical Officer | 03 Jan 2022 | 3,328 | 1,366,718 | - | 17.4 | 57,944 | Common Stock | |
| Samuel Blackman | Chief Medical Officer | 03 Jan 2022 | 6,672 | 1,370,046 | - | 16.9 | 113,074 | Common Stock | |
| Dan Becker | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 01 Jun 2021 | 5,000 | 5,000 | - | 16 | 80,000 | Common Stock |
| Dan Becker | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 63,000 | 63,000 | - | - | Stock Option (right to buy Common Stock) | |
| John A. Josey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 1,181 | 1,181 | - | - | Stock Option (right to buy Common Stock) | |
| John A. Josey | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 63,000 | 63,000 | - | - | Stock Option (right to buy Common Stock) | |
| John A. Josey | Director | Purchase of securities on an exchange or from another person at price $ 16.00 per share. | 01 Jun 2021 | 7,000 | 72,292 | - | 16 | 112,000 | Common Stock |